Drug intelligence / Profile preview

LenVitol

Development stage
Unknown
Lead developer
OLEOFARM
Modality
Small Molecules
Administration
Oral
01

Overview

LenVitol is a dietary supplement developed and manufactured by Oleofarm, consisting of high-quality, cold-pressed flaxseed oil (olej lniany). It is characterized by a high concentration of polyunsaturated fatty acids, specifically alpha-linolenic acid (ALA, an omega-3) and linoleic acid (LA, an omega-6). ALA is an essential fatty acid that the human body cannot synthesize, and its consumption is associated with the maintenance of normal blood cholesterol levels when unsaturated fats replace saturated fats in the diet. LenVitol is marketed for general cardiovascular support and nutritional supplementation, and it is frequently utilized as a component of the Dr. Budwig diet protocol. The product is produced from selected high-linolenic flax seeds using traditional cold-pressing methods to ensure the preservation of its natural bioactive components and nutritional integrity.

Brand names
LenVitol
Other names
LenVitol olej lnianyOleofarm LenVitol
02

Targets

FFAR4 (Free fatty acid receptor 4)FFAR1 (Free fatty acid receptor 1)

Beyond the preview

Go deeper on LenVitol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LenVitol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call